Induction of Autophagy by Vasicinone Protects Neural Cells from Mitochondrial Dysfunction and Attenuates Paraquat-Mediated Parkinson's Disease Associated α-Synuclein Levels

Nutrients. 2020 Jun 7;12(6):1707. doi: 10.3390/nu12061707.

Abstract

Mitochondrial dysfunction and disturbed mitochondrial dynamics were found to be common phenomena in the pathogenesis of Parkinson's disease (PD). Vasicinone is a quinazoline alkaloid from Adhatoda vasica. Here, we investigated the autophagy/mitophagy-enhancing effect of vasicinone and explored its neuroprotective mechanism in paraquat-mimic PD modal in SH-SY5Y cells. Vasicinone rescued the paraquat-induced loss of cell viability and mitochondrial membrane potential. Subsequently, the accumulation of mitochondrial reactive oxygen species (ROS) was balanced by an increase in the expression of antioxidant enzymes. Furthermore, vasicinone restored paraquat-impaired autophagy and mitophagy regulators DJ-1, PINK-1 and Parkin in SH-SY5Y cells. The vasicinone mediated autophagy pathways were abrogated by treatment with the autophagy inhibitor 3-MA, which lead to increases α-synuclein accumulation and decreased the expression of p-ULK and ATG proteins and the autophagy marker LC3-II compared to that observed without 3-MA treatment. These results demonstrated that vasicinone exerted neuroprotective effects by upregulating autophagy and PINK-1/Parkin mediated mitophagy in SH-SY5Y cells.

Keywords: Parkinson’s disease; mitophagy; paraquat; reactive oxygen species; vasicinone; α-synuclein.

MeSH terms

  • Alkaloids / isolation & purification
  • Alkaloids / pharmacology*
  • Alkaloids / therapeutic use*
  • Animals
  • Autophagy / drug effects*
  • Autophagy / genetics*
  • Cells, Cultured
  • Justicia / chemistry*
  • Membrane Potential, Mitochondrial / drug effects*
  • Mice
  • Mitochondria / metabolism
  • Mitophagy / drug effects*
  • Mitophagy / genetics*
  • Neuroprotective Agents*
  • Paraquat / adverse effects*
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy*
  • Parkinson Disease, Secondary / metabolism
  • Phytotherapy*
  • Protein Deglycase DJ-1 / metabolism
  • Protein Kinases / metabolism
  • Reactive Oxygen Species / metabolism
  • Ubiquitin-Protein Ligases / metabolism
  • alpha-Synuclein / metabolism*

Substances

  • Alkaloids
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • alpha-Synuclein
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Protein Kinases
  • PTEN-induced putative kinase
  • PARK7 protein, mouse
  • Protein Deglycase DJ-1
  • vasicinone
  • Paraquat